Work

Project 2025: Proposals for the Continued Success of Drug Development in Acute Myeloid Leukemia

Year: 2021
Type: article
Abstract: The Food and Drug Administration Oncology Center of Excellence initiated Project 2025 to develop 5-year goals in specific areas of oncology drug development. This meeting, in October 2020, brought together a panel of regulators and academic experts in acute myeloid leukemia (AML) to discuss opportunities to maximize the success that has recently occurred in AML drug development. The panel discussed challenges and opportunities in clinical trial design and novel endpoints, and outlined key considerations for drug development to facilitate continued growth in the field.
Authors: Daniel A. Pollyea, John Barrett, Courtney D. DiNardo, Laura C. Michaelis, Gail J. Roboz, Robert Q. Le, Kelly J. Norsworthy, R. Angelo de Claro, Marc R. Theoret, Richard Pazdur
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W3214212825
FWCI: 0.446
Cites: 30
Cited by: 4
Related to: 10